World's longest lasting defibrillator backed by warranty.

Longevity calculations are based on real life pacing conditions.¹
Warranty applies regardless of pacing conditions and therapy frequency.²

How PLATINIUM achieves its longevity?

With breakthrough technology that stands the test of time.

High battery capacity in a small size
Advanced QHR™ technology designed exclusively for ICDs.
Optimized battery volume for a higher energy density.

Reforming free capacitors
Benefits of wet tantalum capacitors include:

Stable charge time
No waste of energy due to no additional reforming

Breakthrough technology chip set

Nano-sized circuit
Reduced micro-controller and intrinsic consumption
30% fewer components and improved performance*:
- Increased storage capacity
- Increased processing speed

*Versus previous ICD generation (Paradym RF).

Why longevity matters?

Need to close the gap
Over 60% of defibrillator implants take place in patients less than 70 years old³ and defibrillators patients exhibit long term survival benefits following device implant. Therefore, almost one third of the patients undergo device replacement due to battery depletion.⁴

Clinical burden associated with replacements
Sooner or later, the issue of replacement will arise and with it risks of serious complications.
Replacement procedures are associated with:

2x occurrences of surgical reinterventions for infections or other causes.⁵
5-fold increase ICD lead issues. ⁶

Healthcare costs savings
Extending device longevity has an important effect on the long-term cost of device therapy. Expected average savings per patient implanted over a 15-year time period⁷:

Up to 21% savings for ICDs from 9 to 14 years longevity
Up to 26% savings for CRT-Ds from 6 to 10 years longevity

SonR feature is not available in the USA.

REFERENCES

Functioning conditions for projected longevity: SonR CRT-D models: Biventricular pacing in DDD mode, 30% in atrium, 100% in both ventricles, at 60min^-1, 600 ohm, A and RV pacing amplitude 2.5V, LV pacing amplitude 3V, 0.35ms, 3 max shocks per year, sensor OFF, SonR ON, MP OFF. CRT-D models: Biventricular pacing in DDD mode, 30% in atrium, 100% in both ventricles, at 60min^-1, 600 ohm, A and RV pacing amplitude 2.5V, LV pacing amplitude 3V, 0.35ms, 3 max shocks per year, sensor OFF, MP OFF. DR models: Pacing in SafeR mode, 30% in atrium, 6% in ventricle, at 60min^-1, 600 ohm, 2.5V, 0.35ms, 4 max shocks per year, sensor OFF. VR models: Pacing in VVI mode 6% at 40min^-1, 600 ohm, 2.5V, 0.35ms, 4 max shocks per year, sensor OFF. For all models: the longevities are calculated by taking into account 6 months storage with the following conditions: Remote ON: daily check, 4 follow-ups and 5 full alert reports per year. RF telemetry ON: 45min for ICD / 120min for CRT-Ds at implant + 15min at discharge + 15min in-clinic quarterly FU.
For more details please refer to the following document supplied with the device: U666 – LIMITED WARRANTY for PLATINIUM ICD and CRT-D devices.
Swedish ICD and Pacemaker Registry – Annual statistic report 2014. https ://www.pacemakerregistret.se/icdpmr/start.do.
Ramachandra I. Impact of ICD battery Longevity on Need for Device Replacements-Insight from Veterans Affairs Database. PACE 2010; 33:314-19.
Borleffs CJW, Thijssen J, Mihaly K et al. Recurrent Implantable Cardioverter-Defibrillator Replacement Is Associated with Increasing Risk of Pocket-Related Complications. Pacing Clinical Electrophysiology 2013;33:1013-19.
Lovelock JD, Cruz C, Hoskins MH et al. Generator replacement is associated with an increased rate of ICD alerts. Heart Rhythm 2014;11(10):1785-89.
Boriani G, Braunschweig F, Deharo JC et al. Impact of extending device longevity on the long-term costs of implantable cardioverter-defibrillator therapy: a modelling study with a 15-year time horizon. Europace 2013;15(10):1453-62.